
Vietnam's Ministry of Health has given the green light to the Russian-made cancer drug Pembroria to provide patients with a new treatment option to fight the dreaded disease.
SGGP News reported that the drug, produced by Limited Liability 'PK-137' in Russia and registered through a facility in the United Arab Emirates, has 100 mg of pembrolizumab per 4 ml. It comes as a concentrated solution to be used for intravenous infusion. It has a shelf life of 24 months from the date of manufacture.